Differential regulation of cell cycle characteristics and apoptosis in MMTV-myc and MMTV-ras mouse mammary tumors

Cancer Research

Volumn 57, Issue 4, 1997, Pages 600-603

  Hundley, Jeff E ^a   Koester, Steven K ^b,c   Troyer, Dean A ^a   Hilsenbeck, Susan G ^a   Barrington, Rebecca E ^a,d   Windle, Jolene J ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b CTRC Institute for Drug Development   (United States)

^c BECKMAN COULTER INC   (United States)

^d TEXAS ONCOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BREAST TUMOR; CELL CYCLE; GROWTH RATE; GROWTH REGULATION; MOUSE; NONHUMAN; ONCOGENE C MYC; ONCOGENE RAS; PRIORITY JOURNAL; TRANSGENIC MOUSE; TUMOR GROWTH;

ANIMALS; APOPTOSIS; CELL CYCLE; CELL DIVISION; GENES, CDC; GENES, MYC; GENES, RAS; GENOTYPE; MAMMARY NEOPLASMS, EXPERIMENTAL; MAMMARY TUMOR VIRUS, MOUSE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC;

EID: 0031056820     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Stewart, T. A., Pattengale, P. K., and Leder, P. Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell, 38: 627-637, 1984.
2. Sinn, E., Muller, W., Pattengale, P., Tepler, I., Wallace, R., and Leder, P. Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo. Cell, 49: 465-475, 1987.
3. Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z., and Hancock, D. C. Induction of apoptosis in fibroblasts by c-myc protein. Cell, 69: 119-128, 1992.
4. Rao, L., Debbas, M., Sabbatini, P., Hockenbery, D., Korsmeyer, S., and White, E. The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19 kDa and Bcl-2 proteins. Proc. Natl. Acad. Sci. USA, 89: 7742-7746, 1992.
5. Sala, A., Casella, I., Grasso, L., Bellon, T., Reed, J. C., Miyashita, T., and Peschle, C. Apoptotic response to oncogenic stimuli: cooperative and antagonistic interactions between c-myb and the growth suppressor p53. Cancer Res., 56: 1991-1996, 1996.
6. Shan, B., and Lee, W-H. Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol. Cell. Biol., 14: 8166-8173, 1994.
7. Arends, M. J., McGregor, A. H., Toft, N. J., Brown, E. J. H., and Wyllie, A. H. Susceptibility to apoptosis is differentially regulated by c-myc and mutated Ha-ras oncogenes and is associated with endonuclease availability. Br. J. Cancer, 68: 1127-1133, 1993.
8. Harrington, E. A., Bennett, M. R., Fanidi, A., and Evan, G. I. c-myc induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J., 13: 3286-3295, 1994.
9. Canman, C. E., Gilmer, T. M., Coutts, S. B., and Kastan, M. B. Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes Dev., 9: 600-611, 1995.
10. Debbas, M., and White, E. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev., 7: 546-554, 1993.
11. Hermeking, H., and Eick, D. Mediation of c-myc-induced apoptosis by p53. Science (Washington DC), 265: 2091-2093, 1994.
12. Lowe, S. W., and Ruley, H. E. Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes Dev., 7: 535-545, 1993.
13. Wagner, A. J., Kokontis, J. M., and Hay, N. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce P21/waf1/cip1. Genes Dev., 8: 2817-2830, 1994.
14. Xiao-Qiang, Q., Livingstone, D. M., Daelin, W. G., and Adams, P. D. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. USA, 91: 10918-10922, 1994.
15. 1 arrest. Mol. Cell. Biol., 15: 6045-6054, 1995.
16. Dexter, D. L., Diamond, M., Creveling, J., and Chen, S. F. Chemotherapy of mammary carcinomas arising in ras transgenic mice. Invest. New Drugs, 11: 1993.
17. Hogan, B., Beddington, R., Costantini, F., and Lacy, E. Manipulating the Mouse Embryo: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1994.
18. Gavrieli, Y., Sherman, Y., and Ben-Sasson, S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol., 119: 493-501, 1992.
19. Krishan, A. Rapid flow cytoflouremetric analysis of mammalian cell cycle by propidium iodide staining. J. Cell Biol., 66: 188-195, 1975.
20. Cox, D. R., and Oakes, D. Analysis of Survival Data. New York: Chapman and Hall, 1984.
21. Winer, B. J. Statistical Principles in Experimental Design. New York: McGraw-Hill Book Co., 1971.
22. DePinho, R. A., Schreiber-Agus, N., and Alt, F. W. myc family oncogenes in the development of normal and neoplastic cells. Adv. Cancer Res., 57: 1-46, 1991.
23. Chen, C. H., Zhang, J., and Ling, C. C. Transfected c-myc and c-Ha-ras modulate radiation-induced apoptosis in rat embryo cells. Radiat. Res., 139: 307-315, 1994.
24. Lotem, J., and Sachs, L. Regulation by bcl-2, c-myc, and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation-competent and -defective myeloid leukemic cells. Cell Growth & Differ., 4: 41-47, 1993.
25. Hsu, B., Marin, M. C., El-Naggar, A. K., Stephens, L. C., Brisbay, S., and McDonnell, T. J. Evidence that c-myc mediated apoptosis does not require wild-type p53 during lymphomagenesis. Oncogene, 11: 175-179, 1995.
26. Hermeking, H., Funk, J. O., Reichert, M., Ellwart, J. W., and Eick, D. Abrogation of p53-induced cell cycle arrest by c-myc: evidence of an inhibitor of p21. Oncogene, 11: 1409-1415, 1995.
27. Cooper, G. M. Oncogenes. Boston: Jones and Bartlett, 1990.
28. Lin, H. J., Eviner, V., Prendergast, G. C., White, E. Activated H-ras rescues E1A-induced apoptosis and cooperates with E1A to overcome p53-dependent growth arrest. Mol. Cell. Biol., 15: 4536-4544, 1995.
29. Nooter, K., Boersma, A. W., Oostrum, R. G., Burger, H., Jochemsen, A. G., and Stoter, G. Constitutive expression of the c-Ha-ras oncogene inhibits doxorubicin-induced apoptosis and promotes cell survival in a rhabdomyosarcoma cell line. Br. J. Cancer, 71: 556-561, 1995.
30. Billadeau, D., Jelinek, D. F., Shah, N., LeBien, T. W., and Van Ness, B. Introduction of and activated N-ras oncogene alters the growth characteristics of the interleukin 6-dependent myeloma cell line ANBL6. Cancer Res., 55: 3640-3646, 1995.
31. Kinoshita, T., Yokota, T., Arai, K., and Miyajima, A. Regulation of Bcl-2 expression by oncogenic Ras protein in hematopoietic cells. Oncogene, 10: 2207-2212, 1995.
32. Maruta, H., and Burgess, A. W. Regulation of the Ras signalling network. BioEssays, 16: 489-496, 1994.
33. Hundley, J. E., Koester, S. K., Troyer, D. A., Hilsenbeck, S. G., Subler, M. A., and Windle, J. J. Increased tumor proliferation and genomic instability without decreased apoptosis in MMTV-ras mice deficient in p53. Mol. Cell. Biol., 17: 723-731
34. Darzynkiewicz, Z. Apoptosis in antitumor strategies: modulation of cell cycle or differentiation. J. Cell. Biochem., 56: 1-9, 1994.